Any current/future new fundraising through debt or equity?

The company is undertaking a phased investment approach, currently piloting the CSTP before proceeding with further investments. Peak debt levels by the end of the current year are expected to be around ₹370-450 crores. For ongoing and planned CAPEX (Baroda, Mahad, Bareilly), the company plans to fund approximately 70-75% of the total project cost through debt. Mahad project’s total planned investment is about ₹100 crores, with ₹25-32 crores already invested. No explicit mention of raising equity funds in the transcript. Focus remains on managing internal operations and strategic investment ph

Any current/future capex/capital investment/strategic investment?

The company has ongoing and planned capex across multiple locations: Baroda, Bareilly, and Mahad. Baroda capex balance is around ₹100 crore; Mahad greenfield project expected cost is ₹92-100 crore; Bareilly capex remaining is small (₹6-7 crore). Total capex planned for FY24 is about ₹200-205 crore. Debt funding expected at 70-75% of total project cost, with peak debt around ₹370-380 crore by year-end. Mahad project is phased, with ₹25-32 crore already invested; total planned investment about ₹100 crore. The new plant validation and market capture are expected over 6-9 months, aiming to capture

Future growth expectations in sales/revenue/volumes?

The company anticipates a challenging next 2-3 quarters with subdued demand and pricing pressures, especially in camphor and aroma chemicals divisions. Strong growth is expected in the fragrance division driven by new wins and participation in more projects, though overall industry growth is uncertain. Capacity expansions (Brownfield and Greenfield) are ongoing, expected to complete by FY24, potentially enabling higher volumes in 2-3 years. Management aims for profitable growth focusing on efficient raw material procurement, cost reduction, and process improvements rather than just volum

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects a challenging next 2-3 quarters due to subdued demand, pricing pressure, and external factors, particularly in camphor and aroma chemicals. Management is focusing on internal process improvements and productivity enhancements to remain lean and profitable when demand stabilizes. They are cautious about providing specific guidance for turnover or earnings in the near term due to volatility in raw material prices and market conditions. Capex of around ₹200-205 crore (Baroda, Bareilly, Mahad) is planned for FY24, which will support future capacity and growth once market

Current/ Expected Orderbook/ Pending Orders?

The company indicated that for H1 2023, customer RFQs (Request for Quotations) allocations have been honored to about 60-70%, with the remaining either postponed or canceled, reflecting softness in demand. Inventory buildup is relatively high due to postponed procurements by global customers and slowdown in Europe and America. There is a challenging environment with subdued demand and oversupply, especially in the camphor market. Due to these factors, a clearer picture on order book stabilizing is expected only after two to three quarters. The management prefers not to provide firm guidance at

Oriental Aromatics LtdQ4 FY23Chemicals & Petrochemicals

Oriental Aromatics Ltd Q4 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹607.05P/E: 384.6Market Cap: ₹2.0K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 5

Margin

Category 4

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 5

The company anticipates a challenging next 2-3 quarters with subdued demand and pricing pressures, especially in camphor and aroma chemicals divisions.
Strong growth is expected in the fragrance division driven by new wins and participation in more projects, though overall industry growth is uncertain.
Capacity expansions (Brownfield and Greenfield) are ongoing, expected to complete by FY24, potentially enabling higher volumes in 2-3 years.
Management aims for profitable growth focusing on efficient raw material procurement, cost reduction, and process improvements rather than just volume increase.
Stabilization of demand and pricing is expected after 2-3 quarters, potentially leading to stable EBITDA and higher sales clarity thereafter.
Due to prevailing uncertainties in raw material prices, demand, and competition, precise revenue or volume guidance is deferred until clearer market conditions emerge.

Margin guidance

Category 4

The company expects a challenging next 2-3 quarters due to subdued demand, pricing pressure, and external factors, particularly in camphor and aroma chemicals.
Management is focusing on internal process improvements and productivity enhancements to remain lean and profitable when demand stabilizes.
They are cautious about providing specific guidance for turnover or earnings in the near term due to volatility in raw material prices and market conditions.
Capex of around ₹200-205 crore (Baroda, Bareilly, Mahad) is planned for FY24, which will support future capacity and growth once market conditions improve.
Emphasis remains on profitable growth rather than volume growth alone, aiming to optimize margins via raw material procurement and operational efficiencies.
Recovery and upward trajectory in earnings, ROE, and ROCE are expected to become clearer after 6-8 quarters when the market stabilizes and new capacities come online.

See what Oriental Aromatics Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

The company is undertaking a phased investment approach, currently piloting the CSTP before proceeding with further investments.
Peak debt levels by the end of the current year are expected to be around ₹370-450 crores.
For ongoing and planned CAPEX (Baroda, Mahad, Bareilly), the company plans to fund approximately 70-75% of the total project cost through debt.
Mahad project’s total planned investment is about ₹100 crores, with ₹25-32 crores already invested.
No explicit mention of raising equity funds in the transcript.
Focus remains on managing internal operations and strategic investment phases with controlled debt funding aligned to project progress.

Order book

The company indicated that for H1 2023, customer RFQs (Request for Quotations) allocations have been honored to about 60-70%, with the remaining either postponed or canceled, reflecting softness in demand.
Inventory buildup is relatively high due to postponed procurements by global customers and slowdown in Europe and America.
There is a challenging environment with subdued demand and oversupply, especially in the camphor market.
Due to these factors, a clearer picture on order book stabilizing is expected only after two to three quarters.
The management prefers not to provide firm guidance at this moment due to market uncertainties.
They are seeing increased participation in new fragrance and flavor projects which is helping the fragrance division grow despite overall market challenges.

See what Oriental Aromatics Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

The company has ongoing and planned capex across multiple locations: Baroda, Bareilly, and Mahad.
Baroda capex balance is around ₹100 crore; Mahad greenfield project expected cost is ₹92-100 crore; Bareilly capex remaining is small (₹6-7 crore).
Total capex planned for FY24 is about ₹200-205 crore.
Debt funding expected at 70-75% of total project cost, with peak debt around ₹370-380 crore by year-end.
Mahad project is phased, with ₹25-32 crore already invested; total planned investment about ₹100 crore.
The new plant validation and market capture are expected over 6-9 months, aiming to capture 40-50% market share within 2.5 years.
The company continues to invest strategically while focusing on derisking and China Plus One strategy despite market challenges.
Expansion including the CSTP project expected to complete mostly by FY24.

Track Oriental Aromatics Ltd — get its next earnings analysis in your feed

How does Oriental Aromatics Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisOriental Aromatics Ltd

Rev 5Mar 4

See where Oriental Aromatics Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Oriental Aromatics Ltd rank in Chemicals & Petrochemicals?

Compare Oriental Aromatics Ltd against every Chemicals & Petrochemicals company (Q4 FY23) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Oriental Aromatics Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks
NOCIL Ltd (Q2 FY27)
427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →